SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Clara Barton Synthetic CCD

PatientClara Barton
Date of birth1973-12-25
IdentifiersMRN HR-NI024-SYN; SSN (made up) 000-24-3357
Document date2026-11-01
AuthorEleanor Whitcombe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deployment. Concerns: Exhausted, low, and sleeping three or four hours a night since coming home; feels she is no use to anyone; Worried that stopping work would let down the families and staff who rely on her, and wonders whether she simply needs a long rest. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-01-20 to 2026-03-03completedS
Sertraline 100 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-03-03activeS
Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 7 daysOne tablet up to three times a day with food, for no more than 7 daysOral route2026-07-27 to 2026-08-02completedS

Procedures

ProcedureDatesStatusEvidence
Advance care planning conversation, about 20 minutes2026-10-13 to 2026-10-13completedS

Immunizations

DateVaccineStatusEvidence
2025-10-06Influenza vaccine, 2025-2026 seasoncompletedS
2024-05-13Tdap vaccine, before deploymentcompletedS
2026-10-13Influenza vaccine, 2026-2027 seasoncompletedS
2026-10-13Pneumococcal conjugate vaccine PCV20completedS
2026-10-13Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
Spring 1852Brief period of depression recorded in her diary while teachingD (CLM-0002)
September 1862Typhoid fever after several days tending the wounded at AntietamD (CLM-0003)
December 1868Loss of voice during a lecture from fatigue and mental prostration, then helpless through the winter; went to Europe on medical advice the next autumnD (CLM-0006, CLM-0007)
1872 to 1873Nervous exhaustion with temporary loss of eyesight; confined to bed for eight months with a cough in EnglandD (CLM-0009)
October 1873Breakdown with prostration of the nervous system after returning homeD (CLM-0010)

Family History

RelativeConditionAge at deathEvidence
motherDied in 1851; cause not recorded in the cited sourceD (CLM-0016)
fatherDied in 1862; cause not recorded in the cited sourceD (CLM-0016)

Health Concerns

ConcernStatusEvidence
Exhausted, low, and sleeping three or four hours a night since coming home; feels she is no use to anyoneactiveS
Worried that stopping work would let down the families and staff who rely on her, and wonders whether she simply needs a long restactiveS

Assessment

Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-10-13; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 on 2026-10-13; PC-PTSD-5 score [PC-PTSD-5] 2 on 2026-01-20; Total score [AUDIT-C] 1 on 2026-10-13; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-01-20; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-01-20; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 2026-01-20; Urea nitrogen [Mass/volume] in Serum or Plasma 14 on 2026-01-20; Creatinine [Mass/volume] in Serum or Plasma 0.78 on 2026-01-20; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 91 on 2026-01-20; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-01-20; Hemoglobin [Mass/volume] in Blood 13.1 on 2026-01-20; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 2026-01-20; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 486 on 2026-01-20; Cholesterol [Mass/volume] in Serum or Plasma 196 on 2026-10-13; Cholesterol in HDL [Mass/volume] in Serum or Plasma 64 on 2026-10-13; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 2026-10-13; Triglyceride [Mass/volume] in Serum or Plasma 98 on 2026-10-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 2026-10-13 [S]

Strengths and supports: Supports: a few close friends from earlier relief work, colleagues at the agency, and a faith community; no firearms in the home [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostrationactiveconfirmed F33.1S — Synthetic modern diagnosis. Her periods of depression and nervous prostration are documented in her own words (D); calling them major depression is a retrospective interpretation (R), and no diagnosis was made in her lifetime.
Occupational burnout after eighteen months leading field medical relief in a war zoneactiveconfirmed Z73.0S — Synthetic contributing factor echoing her documented exhaustion after wartime relief work; burnout is an occupational phenomenon, not a mental disorder.
Acute low back strain after lifting supply crates, without red flags or radicular signs; resolvedresolvedconfirmed S39.012AS — Synthetic strain at an unscheduled visit, chosen to teach NSAID and SSRI bleeding risk and activity advice during depression continuation treatment; it does not echo any documented injury.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]18{score}S
2026-01-20Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
2026-01-20PC-PTSD-5 score [PC-PTSD-5]2{score}S
2026-01-20Total score [AUDIT-C]2{score}S
2026-01-20Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-01-20Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-01-20Carbon dioxide, total [Moles/volume] in Serum or Plasma25mmol/L22-29 mmol/LNormalS
2026-01-20Urea nitrogen [Mass/volume] in Serum or Plasma14mg/dL6-21 mg/dLNormalS
2026-01-20Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-01-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-01-20Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-01-20Hemoglobin [Mass/volume] in Blood13.1g/dL12-15.5 g/dLNormalS
2026-01-20Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4 mIU/LNormalS
2026-01-20Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma486pg/mL232-1245 pg/mLNormalS
2026-02-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]16{score}S
2026-03-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]12{score}S
2026-04-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-04-14Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S
2026-06-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-13Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-10-13Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]2{score}S
2026-10-13Total score [AUDIT-C]1{score}S
2026-10-13Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=199 mg/dLNormalS
2026-10-13Cholesterol in HDL [Mass/volume] in Serum or Plasma64mg/dL>=50 mg/dLNormalS
2026-10-13Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-10-13Triglyceride [Mass/volume] in Serum or Plasma98mg/dL<=149 mg/dLNormalS
2026-10-13Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-01-20Body height152cmS
2026-01-20Body weight49.8kgS
2026-01-20Body mass index (BMI) [Ratio]21.6kg/m2S
2026-01-20Systolic blood pressure118mm[Hg]S
2026-01-20Diastolic blood pressure74mm[Hg]S
2026-01-20Heart rate82/minS
2026-01-20Respiratory rate14/minS
2026-01-20Body temperature36.6CelS
2026-01-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-02-03Body height152cmS
2026-02-03Body weight49.6kgS
2026-02-03Body mass index (BMI) [Ratio]21.5kg/m2S
2026-02-03Systolic blood pressure116mm[Hg]S
2026-02-03Diastolic blood pressure72mm[Hg]S
2026-02-03Heart rate78/minS
2026-02-03Respiratory rate14/minS
2026-02-03Body temperature36.5CelS
2026-02-03Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-03-03Body height152cmS
2026-03-03Body weight50.2kgS
2026-03-03Body mass index (BMI) [Ratio]21.7kg/m2S
2026-03-03Systolic blood pressure120mm[Hg]S
2026-03-03Diastolic blood pressure76mm[Hg]S
2026-03-03Heart rate76/minS
2026-03-03Respiratory rate14/minS
2026-03-03Body temperature36.6CelS
2026-03-03Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-14Body height152cmS
2026-04-14Body weight50.9kgS
2026-04-14Body mass index (BMI) [Ratio]22kg/m2S
2026-04-14Systolic blood pressure118mm[Hg]S
2026-04-14Diastolic blood pressure74mm[Hg]S
2026-04-14Heart rate72/minS
2026-04-14Respiratory rate14/minS
2026-04-14Body temperature36.6CelS
2026-04-14Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-16Body height152cmS
2026-06-16Body weight51.6kgS
2026-06-16Body mass index (BMI) [Ratio]22.3kg/m2S
2026-06-16Systolic blood pressure120mm[Hg]S
2026-06-16Diastolic blood pressure74mm[Hg]S
2026-06-16Heart rate70/minS
2026-06-16Respiratory rate14/minS
2026-06-16Body temperature36.7CelS
2026-06-16Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-07-27Body height152cmS
2026-07-27Body weight51.8kgS
2026-07-27Body mass index (BMI) [Ratio]22.4kg/m2S
2026-07-27Systolic blood pressure128mm[Hg]S
2026-07-27Diastolic blood pressure80mm[Hg]S
2026-07-27Heart rate84/minS
2026-07-27Respiratory rate16/minS
2026-07-27Body temperature36.7CelS
2026-07-27Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-13Body height152cmS
2026-10-13Body weight52kgS
2026-10-13Body mass index (BMI) [Ratio]22.5kg/m2S
2026-10-13Systolic blood pressure118mm[Hg]S
2026-10-13Diastolic blood pressure72mm[Hg]S
2026-10-13Heart rate68/minS
2026-10-13Respiratory rate14/minS
2026-10-13Body temperature36.6CelS
2026-10-13Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-01-20Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deploymentfinishedS
2026-02-03Two-week sertraline tolerability and safety check, with psychiatry consultationfinishedS
2026-03-03Six-week depression treatment reviewfinishedS
2026-04-14Twelve-week depression treatment reviewfinishedS
2026-06-16Five-month depression review in continuation treatmentfinishedS
2026-07-27Same-day sick visit for low back pain after liftingfinishedS
2026-10-13Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Shared decision-making: combined psychotherapy and an antidepressant for a recurrent, moderately severe episode; she chose cognitive behavioral therapy and sertralinecompletedGL-MDD-2022, GL-CMID-2026S
Start sertraline 50 mg each morning; check tolerability and safety at two weeks; increase to 100 mg if the PHQ-9 has fallen by less than 50 percent after four to six weekscompletedGL-MDD-2022, GL-CMID-2026S
Weekly cognitive behavioral therapy with the clinic psychologist, by video or in person, for about 16 sessions, including behavioral activation and insomnia componentscompletedGL-MDD-2022, GL-CMID-2026S
Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; medicines stored safely and dispensed in 30-day suppliescompletedGL-SUICIDE-2024S
Psychiatry consultation to confirm the diagnosis, exclude bipolar disorder and PTSD, and advise on treatment of a recurrent episodecompletedGL-MDD-2022, GL-CMID-2026S
PHQ-9 at every visit and at least monthly until remission; suicide-risk review at every visit; continue sertraline for at least twelve months after remission because the episode is recurrentcompletedGL-MDD-2022, GL-CMID-2026, GL-SUICIDE-2024S
Burnout and work: two weeks of medical leave, then a phased return with a 45-hour cap, no field deployment for at least six months, delegation of the families' correspondence, and a peer support group for relief workerscompletedGL-MDD-2022, GL-CMID-2026S
Sleep and activity: fixed wake time, no work after 8 pm, a daily 30-minute walk, regular meals, and limited alcohol; prolonged bed rest or withdrawal from activity is explained as unhelpful for depressioncompletedGL-MDD-2022, GL-CMID-2026S
Screen for bipolar disorder, PTSD, anxiety, and unhealthy alcohol use, and check thyroid, blood count, vitamin B12, and a metabolic panel for medical contributors to fatiguecompletedGL-MDD-2022, GL-CMID-2026, GL-USPSTF-DEP-2023S

Goals

GoalTargetStatusOutcomeProvenance
Response (PHQ-9 down by at least 50 percent) by twelve weeks2026-04-14completedPHQ-9 7 at twelve weeks, down 61 percent from 18S
Remission (PHQ-9 below 5) and continuation treatment for at least twelve months after remission2026-06-16activeRemission reached at five months (PHQ-9 4); continuation treatment under wayS
Sleep at least six hours most nights2026-04-14completedAbout six and a half hours most nights by twelve weeksS
Phased return to work at no more than 45 hours a week, with no field deployment for at least six months2026-06-16completedFull duties at 45 hours a week from April; no deploymentS
Time with friends or her faith community at least twice a week2026-06-16completedWeekly dinner with friends and weekly servicesS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-01-20: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, safe storage of medicines, and a two-week follow-up [S]